Medicare Enrolled
Dr. Paul Haver, M.D.
Family Medicine · Athens, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Haver from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Haver?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Haver
Dr. Paul Haver is a family medicine specialist in Athens, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Haver performed 1,710 Medicare services across 1,174 unique beneficiaries.
Between the years covered by Open Payments, Dr. Haver received a total of $9,712 from 57 pharmaceutical and/or device companies across 670 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Haver is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 21% volume in GA
$9,712 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,710
Medicare services
Top 21% in GA for family medicine
1,174
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
440 | $79 | $210 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
178 | $8 | $13 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
177 | $120 | $223 |
| Annual depression screening | 174 | $17 | $34 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
171 | $75 | $161 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
171 | $0 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
140 | $54 | $140 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
61 | $9 | $32 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
44 | $9 | $48 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
35 | $4 | $18 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
25 | $3 | $18 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
22 | $35 | $80 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
17 | $0 | $40 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
15 | $98 | $280 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
14 | $205 | $444 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
13 | $11 | $82 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
13 | $24 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,712
Total received (2018-2024)
Avg $1,387/year across 7 years
Top 6% in GA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
670
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,712 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,385
2023
$1,375
2022
$1,354
2021
$1,122
2020
$963
2019
$1,453
2018
$2,060
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$220
Lilly USA, LLC
$186
AstraZeneca Pharmaceuticals LP
$164
PFIZER INC.
$149
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
Bayer Healthcare Pharmaceuticals Inc.
$84
Abbott Laboratories
$72
Otsuka America Pharmaceutical, Inc.
$70
GlaxoSmithKline, LLC.
$58
Amgen Inc.
$56
Exact Sciences Corporation
$38
Astellas Pharma US Inc
$38
ABBVIE INC.
$32
Corcept Therapeutics
$30
Novartis Pharmaceuticals Corporation
$29
Boston Scientific Corporation
$24
Lundbeck LLC
$16
IDORSIA PHARMACEUTICALS US INC
$15
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$14
Top 3 companies account for 41.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,184
AstraZeneca Pharmaceuticals LP
$1,066
Lilly USA, LLC
$699
Amgen Inc.
$672
Boehringer Ingelheim Pharmaceuticals, Inc.
$625
PFIZER INC.
$570
GlaxoSmithKline, LLC.
$400
Takeda Pharmaceuticals U.S.A., Inc.
$331
Abbott Laboratories
$304
ABBVIE INC.
$238
Teva Pharmaceuticals USA, Inc.
$238
SANOFI-AVENTIS U.S. LLC
$231
Novartis Pharmaceuticals Corporation
$210
Corcept Therapeutics
$200
Janssen Pharmaceuticals, Inc
$191
Otsuka America Pharmaceutical, Inc.
$173
Bayer Healthcare Pharmaceuticals Inc.
$171
Shire North American Group Inc
$164
Merck Sharp & Dohme Corporation
$153
Biohaven Pharmaceuticals, Inc.
$146
Kowa Pharmaceuticals America, Inc.
$130
IDORSIA PHARMACEUTICALS US INC
$125
E.R. Squibb & Sons, L.L.C.
$111
Astellas Pharma US Inc
$109
Allergan Inc.
$98
Amarin Pharma Inc.
$85
AbbVie, Inc.
$80
AbbVie Inc.
$73
Allergan, Inc.
$67
Bardy Diagnostics, Inc.
$61
Genentech USA, Inc.
$60
Mannkind Corporation
$59
Exact Sciences Corporation
$58
ARBOR PHARMACEUTICALS, INC.
$57
Medtronic Vascular, Inc.
$47
Insulet Corporation
$43
Avanir Pharmaceuticals, Inc.
$41
Biohaven Pharmaceutical Holding Company Ltd.
$39
Hikma Pharmaceuticals USA
$38
Scilex Pharmaceuticals Inc.
$37
Lundbeck LLC
$32
Arbor Pharmaceuticals, Inc.
$30
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$28
Kerecis Limited
$27
Boston Scientific Corporation
$24
West-Ward Pharmaceuticals
$20
Sunovion Pharmaceuticals Inc.
$20
Nalpropion Pharmaceuticals LLC
$20
Synergy Pharmaceuticals Inc
$17
Medtronic MiniMed, Inc.
$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$14
Currax Pharmaceuticals LLC
$14
Orexigen Therapeutics, Inc.
$14
Aytu BioScience, Inc
$13
Circassia Pharmaceuticals Inc
$13
Endo Pharmaceuticals Inc.
$13
Ironwood Pharmaceuticals, Inc
$11
Top 3 companies account for 30.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · AJOVY · ANORO ELLIPTA · AREXVY · AVEED · Aimovig · Amitiza · BEVESPI AEROSPHERE · BOOSTRIX · BREZTRI · BYSTOLIC · CAPLYTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · Carnation Ambulatory Monitor · ClosureFast · Cologuard Collection Kit · DUZALLO · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · FASENRA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · FreeStyle Lite system · GARDASIL 9 · INVOKANA · JANUMET · JANUVIA · JARDIANCE · Kerecis Omega3 SurgiClose · Kerendia · Korlym · LEQVIO · LINZESS · LYRICA · Livalo · MOUNJARO · MYDAYIS · Minimed 630G · Mitigare · Myrbetriq · NUEDEXTA · NURTEC ODT · Natesto · ONZETRA Xsail · Omnipod · Ozempic · PAXLOVID · PNEUMOVAX 23 · Prolia · QULIPTA · QUVIVIQ · QVAR · RELISTOR · REXULTI · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trintellix · Trulance · UBRELVY · UTIBRON · Uloric · VIIBRYD · VRAYLAR · VYVANSE · Vascepa · VenaSeal · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xofluza · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for family medicine in GA.
Geographic Context
Family medicine physicians within 10 mi
126
Per 100K population
97.5
County median income
$52,267
Nearest hospital
ST MARY'S HOSPITAL
6.7 mi
6.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Haver is a clinical cardiology specialist, with above-average Medicare volume (top 21% in GA), with low-engagement industry engagement in the top 6% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Haver experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Haver performed 440 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Haver receive payments from pharmaceutical companies?
Yes. Dr. Haver received a total of $9,712 from 57 companies across 670 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Haver's costs compare to other family medicine physicians in Athens?
Dr. Haver's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Haver) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Athens
Browse family medicine physicians in Athens ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in GA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in GA
Which GA family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology